Table 1.
Demographic and Clinical Characteristics of HIV-Infected and HIV-Uninfected Men From the Multicenter AIDS Cohort Study
| Characteristic | Median (IQR)a |
||
|---|---|---|---|
| HIV Uninfected (n = 200) | HIV Infected (n = 434) | Overall (N = 634) | |
| Black, % | 38 | 37 | 37 |
| Age, yb | 53 (48–60) | 51 (46–57) | 52 (47–58) |
| Weight, kgb | 84 (75–94) | 79 (71–89) | 81 (72–91) |
| BMI, kg/m2b | 27 (24–30) | 26 (23–28) | 26 (24–29) |
| BSA, m2b | 2.0 (1.9–2.2) | 2.0 (1.9–2.1) | 2.0 (1.9–2.1) |
| Serum creatinine, mg/dL | 0.88 (0.78–1.02) | 0.87 (0.75–1.04) | 0.88 (0.76–1.03) |
| Cystatin C, mg/Lb,c | 0.75 (0.67–0.85) | 0.79 (0.69–0.94) | 0.77 (0.68–0.90) |
| uPCr, mg/gb,c | 65 (48–90) | 98 (69–165) | 85 (60–138) |
| GFR, mL/min/1.73 m2 | 106 (95–120) | 109 (92–125) | 107 (92–123) |
| HCV-infected, %c | 16 | 16 | 15 |
| History of risk factors, % | |||
| Diabetes mellitus | 14 | 17 | 16 |
| Hypertension | 59 | 56 | 57 |
| Dyslipidemiab | 78 | 92 | 87 |
| HIV-related factors | |||
| Time since HIV-infection, y | … | 19 (19–26) | … |
| Time since HAART initiation, y | … | 10 (7–12) | … |
| History of AIDS, % | … | 15 | … |
| HIV RNA <50 copies/mL, % | … | 80 | … |
| CD4+ T-cell count, cells/μL | … | 544 (388–741) | … |
Abbreviations: BMI, body mass index; BSA, body surface area; GFR, glomerular filtration rate; HAART, highly active antiretroviral therapy; HCV, hepatitis C virus; HIV, human immunodeficiency virus; IQR, interquartile range; uPCr, urine protein-creatinine ratio.
a Data represent median (IQR) values unless otherwise specified. Values were obtained from the kidney function assessment visit or the nearest visit before that.
b P < .05 (χ2 test or Kruskal–Wallis for comparison between HIV-uninfected and HIV-infected participants).
c Data were missing on HCV status for 4 participants, on cystatin C level, for 3, and on uPCr for 8.